Bolivia vs Cameroon: HIV expenditure on prevention and treatment
Bolivia
0 constant 2019 US$
in 2022
Cameroon
0 constant 2019 US$
in 2022
Bolivia rank
101st
Cameroon rank
101st
HIV expenditure on prevention and treatment over time
- Bolivia
- Cameroon
How they compare
Bolivia currently reports 0 constant 2019 US$ against 0 constant 2019 US$ in Cameroon, a difference of 0 constant 2019 US$.
Across all 9 years both countries report, Cameroon has been ahead every year.
Bolivia ranks 101st and Cameroon ranks 101st of 144 countries.
Cameroon has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bolivia | Cameroon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.83 million constant 2019 US$ | 47.39 million constant 2019 US$ | 42.56 million constant 2019 US$ | Cameroon |
| 2010s | 7.01 million constant 2019 US$ | 32.94 million constant 2019 US$ | 25.93 million constant 2019 US$ | Cameroon |
| 2020s | 0 constant 2019 US$ | 0 constant 2019 US$ | 0 constant 2019 US$ | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv expenditure on prevention and treatment, Bolivia or Cameroon?
- Bolivia, at 0 constant 2019 US$ against 0 constant 2019 US$ in Cameroon as of 2022.
- What is the difference in hiv expenditure on prevention and treatment between Bolivia and Cameroon?
- 0 constant 2019 US$, with Bolivia ahead.
- How many years of comparable data are there for Bolivia and Cameroon?
- 9 years are reported by both, from 2005 to 2022.
- How do Bolivia and Cameroon rank globally for hiv expenditure on prevention and treatment?
- Bolivia ranks 101st and Cameroon ranks 101st of 144 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV expenditure on prevention and treatment. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Total in-country spending on HIV programs and services.